Dynamic Technology Lab’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,956
Closed -$223K 960
2026
Q1
$223K Buy
+16,956
New +$254K 0.04% 710

Other funds holding NPCE

Dynamic Technology Lab's NPCE Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 16,956 shares — an estimated $223K sold.

Dynamic Technology Lab first reported a position in NPCE in Q1 2026 and held it in 1 quarter. The position peaked at $223K in Q1 2026. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Dynamic Technology Lab reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 16,956 Neuropace shares in Q2 2026, an estimated $223K.
  • Dynamic Technology Lab first reported a position in Neuropace in Q1 2026 and held it in 1 quarter.
  • Dynamic Technology Lab's Neuropace position peaked at $223K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.